Cite

HARVARD Citation

    Yu, L. et al. (2019). High‐dose PPI‐amoxicillin dual therapy with or without bismuth for first‐line Helicobacter pylori therapy: A randomized trial. Helicobacter. 24 (4), p. n/a. [Online]. 
  
Back to record